Blood Pressure Lowering and Natriuretic Effects of LCZ696 in Patents with Hypertension: A Randomized, Double-Blind, Controlled, Crossover Study

Authors
Kobalava Z. 1 , Kotovskaya Y. 1 , Villevalde S. 1 , Moiseev V. 1 , Albrecht D. 2 , Chandra P. 2 , Casagrande L. 3
Conference proceedings
JOURNAL OF CLINICAL HYPERTENSION
Publisher
WILEY-BLACKWELL
Language
English
Status
Published
Volume
15
Year
2013
Organizations
  • 1 Peoples Friendship Univ Russia, Moscow, Russia
  • 2 Novartis Inst Biomed Res, Basel, Switzerland
  • 3 Clinbay Stat Solut Drug Dev, Brussels, Belgium
Keywords
LCZ696; valsartan; blood pressure; natriuresis
Date of creation
19.10.2018
Date of change
22.03.2022
Short link
https://repository.rudn.ru/en/records/article/record/8484/
Share

Other records